Tilray Brands, Inc. TLRY

Alternate Symbol(s): T.TLRY

Healthcare Cannabis

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.

NDAQ:TLRY - Post by User

Tilray Brands, Inc.

<< Previous

Bullboard Posts

Next >>

Post by Ventura2020on Mar 23, 2024 5:51pm

191 Views

Post# 35949057

LP’s Set to Dominate Germany

Cannabis Stocks Set To Dominate Germany's New Market: A Surge In Demand Meets Established Expertise.

https://markets.businessinsider.com/news/stocks/cannabis-stocks-set-to-dominate-germany-s-new-market-a-surge-in-demand-meets-established-expertise-1033189888

Germany's historic step towards cannabis legalization, effective April 1, 2024, opens a new chapter in the global cannabis industry, presenting substantial opportunities for Canadian leaders Aurora (NASDAQ:ACB), Canopy Growth (NASDAQ:CGC), and Tilray (NASDAQ:TLRY).

Germany will become Europe's third country to regulate cannabis for adults. Cannabis clubs with up to 500 members will be able to grow and purchase marijuana while public cannabis use will be allowed away from children and sports facilities, and banned in pedestrian zones during the day.

The landmark reclassification of cannabis, enhancing accessibility, and reducing regulatory complexities for medical cannabis, catalyze a market poised for growth.

With the German cannabis market projected to expand to €1.7 billion by 2025, from a relatively modest base of 28,000 patients in 2023, the stage is set for Canadian exporters to capture significant market share.

These and other hot topics will be discussed at the April 16-17 Benzinga Cannabis Capital Conference, especially given how marijuana stocks shot up in response.